Image 3-Bamlanivimab (LY-Cov555) - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Bamlanivimab (LY-Cov555) for the Treatment of Covid-19

Image 3-Bamlanivimab (LY-Cov555)
Bamlanivimab is a neutralising monoclonal antibody. Credit: Eli Lilly and Company.